(PharmaNewsWire.Com, August 16, 2017 ) Europe In-vitro Toxicology Testing Industry is expected to reach USD 8.40 billion by 2021 from USD 4.60 billion in 2016, growing at a CAGR of 12.80% for the next five years 2016-2021. In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time. Browse market data tables and in-depth TOC of the Global Antibodies Market to 2021 @ http://www.marketdataforecast.com/market-reports/europe-in-vitro-toxicology-testing-market-229/ Increasing chronic diseases, growing aging population, rising technological advancements, growing demand for healthy life style, availability of government supported anti-animal testing laws, and existence of favorable regulatory policies (such as European government banned the production & sale of all animal tested cosmetics in Europe) are driving the growth of in-vitro toxicology testing market in Europe. However, high cost of technologies and lack of awareness on the in-vitro toxicology testing utilization are restraining the growth of in-vitro toxicology testing market in Europe. Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-in-vitro-toxicology-testing-market-229/request-sample Market Segmentation • Product Assays Reagents & Labware Services Growth Hormone Therapy • Type ADME (Absorption, Distribution, Metabolism, and Excretion) Dose Toxic Substance • Toxicity Endpoints & Tests Systemic Toxicity Dermal Toxicity Carcinogenicity Ocular Toxicity Skin Sensitization & Irritation Genotoxicity Neurotoxicity Organ Toxicity Other Toxicity Endpoints & Tests • Technology OMICS Technologies Cell Culture Technology High-Throughput Technologies Molecular Imaging Technologies • Method In-Silico Methods Biochemical Assays Cellular Assays Ex-Vivo Models • Industry Cosmetics and Household Products Diagnostics Pharmaceuticals Food Industry Chemicals Avail discount @ http://www.marketdataforecast.com/market-reports/europe-in-vitro-toxicology-testing-market-229/request-discount On the basis of geographical areas, Europe in-vitro toxicology testing market is segmented as U.K., Germany, France, Italy, and Spain. Germany is estimated to account for the largest share of the Europe in-vitro toxicology testing market in 2016, whereas France is estimated to grow at the highest CAGR during the forecast period 2016-2021. The key players in in-vitro toxicology testing market include, Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.), among others. Buy now Report @ https://www.marketdataforecast.com/cart/buy-now/europe-in-vitro-toxicology-testing-market-229
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
